FY2025 · ended Dec 31, 2025 · Revenue $22.36M, -17.3% YoY · Filed Mar 19, 2026
DarioHealth Corp. (DRIO) files with the SEC under industry code 3841, Surgical & Medical Instruments & Apparatus. In fiscal 2025, which ended Dec 31, 2025, it reported revenue of $22.4 million and a net loss of $41.7 million. Free cash flow was -$26.1 million. As of Jun 30, 2026 it held $14.0 million in cash and investments and $32.4 million in total debt.
Revenue (TTM)
$21.00M
-22.7% vs year-ago TTM
Net income (TTM)
$-35.67M
+19.3% vs year-ago TTM
Operating cash flow (TTM)
$-25.34M
+5.4% vs year-ago TTM
Free cash flow (TTM)
$-25.48M
+5.3% vs year-ago TTM
EPS (TTM)
$-4.85
-266.1% vs year-ago TTM
Dividend per share
None
Shares outstanding
7.30M
-82.4% vs prior year
Net cash
$-18.45M
as of Jun 30, 2026
Operating margin
-151.6%
FY 2026
Company profile
- Industry
- Surgical & Medical Instruments & Apparatus (SIC 3841)
- Listed as
- DRIO (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- New York, NY
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1533998
- Former names
- LabStyle Innovations Corp. (until Jul 27, 2016)
Other Surgical & Medical Instruments & Apparatus companies
- Stryker Corp SYK
- 3M Co MMM
- Boston Scientific Corp BSX
- Becton Dickinson & Co BDX
- Medline Inc. MDLN
- Resmed Inc RMD
- Dexcom Inc DXCM
- Fresenius SE & Co. KGaA FSNUY
All 151 Surgical & Medical Instruments & Apparatus companies
Key figures
Fiscal-year totals from the annual reports. Balance sheet lines are as of each year end.
| Line | FY 2025 Dec 31, 2025 |
FY 2024 Dec 31, 2024 |
FY 2023 Dec 31, 2023 |
FY 2022 Dec 31, 2022 |
FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $22.4M | $27.0M | $20.4M | $27.7M | $20.5M |
| Operating income | -$36.7M | -$57.7M | -$56.2M | -$56.8M | -$76.5M |
| Net income | -$41.7M | -$42.7M | -$59.4M | -$62.2M | -$76.8M |
| Diluted EPS | $10.12 | $12.27 | $1.93 | $2.54 | $4.07 |
| Operating cash flow | -$25.9M | -$38.6M | -$30.4M | -$47.8M | -$50.4M |
| Free cash flow | -$26.1M | -$38.7M | -$31.0M | -$48.3M | -$50.7M |
| Total assets | $110.1M | $118.9M | $96.4M | $119.2M | $100.8M |
| Stockholders' equity | $67.9M | $72.0M | $58.1M | $80.0M | $85.5M |
| Cash and investments | $21.8M | $27.8M | $36.8M | $49.4M | $35.8M |
| Total debt | $31.7M | $30.2M | $29.5M | $19.2M | $287,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Sep 4, 2026 | Sep 2, 2026 |
| 8-K |
Current report
Officer or director change
|
Aug 21, 2026 | Aug 20, 2026 |
| 10-Q | Quarterly report | Aug 11, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Material agreement, Other events
|
Jul 22, 2026 | Jul 22, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 10, 2026 | Jul 10, 2026 |
| 10-Q | Quarterly report | May 13, 2026 | Mar 31, 2026 |
All 903 DarioHealth Corp. SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.